FDA Inspection 732327 — Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. on June 10, 2011 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 10, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)